Luciole Pharmaceuticals, Inc.

📍 Natick, United States🗓 Founded 2020👥 3 employees💰 Last funded Jul 2021
Biotechnology Research🌐 luciolepharma.com
Website LinkedIn
Luciole is a start-up biotechnology company discovering and developing small molecule activators of OGG1, to accelerate the repair of oxidative damage to mitochondrial DNA. Luciole Pharmaceuticals is developing first-in-class agents as disease-modifying therapeutics for diseases of aging. Our efforts have the potential to lead to the discovery of a novel, safe, and very effective oral medicine for obesity and metabolic syndrome, fatty liver disease and neurodegeneration, which will improve patients’ quality-of-life and increase their life expectancy.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2020
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Luciole Pharmaceuticals, Inc.?
Luciole Pharmaceuticals, Inc. has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Luciole Pharmaceuticals, Inc. last raise funding?
The most recent investment in Luciole Pharmaceuticals, Inc. recorded on gritt.io was in July 2021.
When was Luciole Pharmaceuticals, Inc. founded?
Luciole Pharmaceuticals, Inc. was founded in 2020.
What industry is Luciole Pharmaceuticals, Inc. in?
Luciole Pharmaceuticals, Inc. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Luciole Pharmaceuticals, Inc. based?
Luciole Pharmaceuticals, Inc. is headquartered in Natick, United States.